ARAY

Accuray Incorporated Common Stock

$0.18

Current Price

All

AI analysis

Read what the AI thinks of Accuray Incorporated Common Stock in the app.

Analyses are generated by AI from public data and are not investment advice.

Get the app

Key figures

Dividend per share

—

Yield

—

EPS

-$0.41

P/E

—

Data as of Oct 8

Why it matters for the long term

Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings

Expected EPS: -$0.07

Nov 11

Posts

No posts about ARAY yet.

About Accuray Incorporated Common Stock

Accuray makes radiation therapy machines that treat cancer, including the CyberKnife and Radixact systems. Hospitals and cancer centers buy the machines, then pay for service contracts, software upgrades and parts. The recurring service income is the steadier part of the business, while machine sales come in lumps.